Cargando…

Insulin Sensitivity Is Not Decreased in Adult Patients With Hypopituitarism Without Growth Hormone Replacement

Decreased insulin sensitivity in patients with hypopituitarism without GH replacement (pHP-WGHR) remains conflicting in literature. It is known that these patients present a decrease in free fat mass and an increase in fat mass. Typically, these kinds of alterations in body composition are associate...

Descripción completa

Detalles Bibliográficos
Autores principales: Castillo, Alejandro Rosell, de Souza, Aglecio Luiz, Alegre, Sarah Monte, Atala, Yeelen Ballesteros, Zantut-Wittmann, Denise Engelbrecht, Garmes, Heraldo Mendes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692434/
https://www.ncbi.nlm.nih.gov/pubmed/31447781
http://dx.doi.org/10.3389/fendo.2019.00534
_version_ 1783443551563022336
author Castillo, Alejandro Rosell
de Souza, Aglecio Luiz
Alegre, Sarah Monte
Atala, Yeelen Ballesteros
Zantut-Wittmann, Denise Engelbrecht
Garmes, Heraldo Mendes
author_facet Castillo, Alejandro Rosell
de Souza, Aglecio Luiz
Alegre, Sarah Monte
Atala, Yeelen Ballesteros
Zantut-Wittmann, Denise Engelbrecht
Garmes, Heraldo Mendes
author_sort Castillo, Alejandro Rosell
collection PubMed
description Decreased insulin sensitivity in patients with hypopituitarism without GH replacement (pHP-WGHR) remains conflicting in literature. It is known that these patients present a decrease in free fat mass and an increase in fat mass. Typically, these kinds of alterations in body composition are associated with a decrease in insulin sensitivity; however, there is no consensus if this association is found in pHP-WGHR. Thus, we investigated pHP-WGHR regarding insulin sensitivity by euglycemic hyperinsulinemic clamp, the gold standard method, and body composition. In a cross-sectional study, we evaluated 15 pHP-WGHR followed up in a Service of Neuroendocrinology and 15 individuals with normal pituitary function as a control group with similar age, gender and body mass index. Insulin sensitivity was evaluated by euglycemic hyperinsulinemic clamp and homeostatic model assessment insulin resistance (HOMA-IR). Kappa coefficient evaluated the agreement between these two methods. Percentage of fat mass, percentage of free fat mass, fat mass weight and free fat mass weight were assessed by electrical bioimpedance. The pHP-WGHR presented similar insulin sensitivity to control group by euglycemic hyperinsulinemic clamp, both by the M-value, (p = 0.0913) and by the area under the glucose infusion rate curve, (p = 0.0628). These patients showed lower levels of fasting glycemia (p = 0.0128), insulin (p = 0.0007), HOMA-IR (p = 0.009). HOMA-IR shows poor concordance with euglycemic hyperinsulinemic clamp (Kappa = 0.16) in pHP-WGHR, while in the control group the agreement was good (Kappa = 0.53). The pHP-WGHR presented higher values of percentage of fat mass (p = 0.0381) and lower values of percentage of free fat mass (p = 0.0464) and free fat mass weight (0.0421) than the control group. This study demonstrated that the insulin sensitivity evaluated by euglycemic hyperinsulinemic clamp in pHP-WGHR was similar to individuals with normal pituitary function, despite the pHP-WGHR presenting higher fat mass percentage. HOMA-IR was not a good method for assessing insulin sensitivity in pHP-WGHR.
format Online
Article
Text
id pubmed-6692434
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-66924342019-08-23 Insulin Sensitivity Is Not Decreased in Adult Patients With Hypopituitarism Without Growth Hormone Replacement Castillo, Alejandro Rosell de Souza, Aglecio Luiz Alegre, Sarah Monte Atala, Yeelen Ballesteros Zantut-Wittmann, Denise Engelbrecht Garmes, Heraldo Mendes Front Endocrinol (Lausanne) Endocrinology Decreased insulin sensitivity in patients with hypopituitarism without GH replacement (pHP-WGHR) remains conflicting in literature. It is known that these patients present a decrease in free fat mass and an increase in fat mass. Typically, these kinds of alterations in body composition are associated with a decrease in insulin sensitivity; however, there is no consensus if this association is found in pHP-WGHR. Thus, we investigated pHP-WGHR regarding insulin sensitivity by euglycemic hyperinsulinemic clamp, the gold standard method, and body composition. In a cross-sectional study, we evaluated 15 pHP-WGHR followed up in a Service of Neuroendocrinology and 15 individuals with normal pituitary function as a control group with similar age, gender and body mass index. Insulin sensitivity was evaluated by euglycemic hyperinsulinemic clamp and homeostatic model assessment insulin resistance (HOMA-IR). Kappa coefficient evaluated the agreement between these two methods. Percentage of fat mass, percentage of free fat mass, fat mass weight and free fat mass weight were assessed by electrical bioimpedance. The pHP-WGHR presented similar insulin sensitivity to control group by euglycemic hyperinsulinemic clamp, both by the M-value, (p = 0.0913) and by the area under the glucose infusion rate curve, (p = 0.0628). These patients showed lower levels of fasting glycemia (p = 0.0128), insulin (p = 0.0007), HOMA-IR (p = 0.009). HOMA-IR shows poor concordance with euglycemic hyperinsulinemic clamp (Kappa = 0.16) in pHP-WGHR, while in the control group the agreement was good (Kappa = 0.53). The pHP-WGHR presented higher values of percentage of fat mass (p = 0.0381) and lower values of percentage of free fat mass (p = 0.0464) and free fat mass weight (0.0421) than the control group. This study demonstrated that the insulin sensitivity evaluated by euglycemic hyperinsulinemic clamp in pHP-WGHR was similar to individuals with normal pituitary function, despite the pHP-WGHR presenting higher fat mass percentage. HOMA-IR was not a good method for assessing insulin sensitivity in pHP-WGHR. Frontiers Media S.A. 2019-08-07 /pmc/articles/PMC6692434/ /pubmed/31447781 http://dx.doi.org/10.3389/fendo.2019.00534 Text en Copyright © 2019 Castillo, de Souza, Alegre, Atala, Zantut-Wittmann and Garmes. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Castillo, Alejandro Rosell
de Souza, Aglecio Luiz
Alegre, Sarah Monte
Atala, Yeelen Ballesteros
Zantut-Wittmann, Denise Engelbrecht
Garmes, Heraldo Mendes
Insulin Sensitivity Is Not Decreased in Adult Patients With Hypopituitarism Without Growth Hormone Replacement
title Insulin Sensitivity Is Not Decreased in Adult Patients With Hypopituitarism Without Growth Hormone Replacement
title_full Insulin Sensitivity Is Not Decreased in Adult Patients With Hypopituitarism Without Growth Hormone Replacement
title_fullStr Insulin Sensitivity Is Not Decreased in Adult Patients With Hypopituitarism Without Growth Hormone Replacement
title_full_unstemmed Insulin Sensitivity Is Not Decreased in Adult Patients With Hypopituitarism Without Growth Hormone Replacement
title_short Insulin Sensitivity Is Not Decreased in Adult Patients With Hypopituitarism Without Growth Hormone Replacement
title_sort insulin sensitivity is not decreased in adult patients with hypopituitarism without growth hormone replacement
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692434/
https://www.ncbi.nlm.nih.gov/pubmed/31447781
http://dx.doi.org/10.3389/fendo.2019.00534
work_keys_str_mv AT castilloalejandrorosell insulinsensitivityisnotdecreasedinadultpatientswithhypopituitarismwithoutgrowthhormonereplacement
AT desouzaaglecioluiz insulinsensitivityisnotdecreasedinadultpatientswithhypopituitarismwithoutgrowthhormonereplacement
AT alegresarahmonte insulinsensitivityisnotdecreasedinadultpatientswithhypopituitarismwithoutgrowthhormonereplacement
AT atalayeelenballesteros insulinsensitivityisnotdecreasedinadultpatientswithhypopituitarismwithoutgrowthhormonereplacement
AT zantutwittmanndeniseengelbrecht insulinsensitivityisnotdecreasedinadultpatientswithhypopituitarismwithoutgrowthhormonereplacement
AT garmesheraldomendes insulinsensitivityisnotdecreasedinadultpatientswithhypopituitarismwithoutgrowthhormonereplacement